This article has been updated to include comments from a conference call.

NEW YORK (GenomeWeb News) – Caliper Life Sciences today said that it has sold its Xenogen Biosciences subsidiary to Taconic Farms for approximately $11 million.

Xenogen Biosciences provides in vivo pre-clinical CRO services and became part of Caliper through the acquisition of Xenogen Corp. in 2006.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.